CAT Catco Reinsurance Opportunities Fund Limited

RNS Number:2570O
Cambridge Antibody Tech Group PLC
5 December 2001

The issuer advises the following replaces the Director Shareholding
announcement released today at

17:24 under RNS Number 2514O.

Point 20 in the form for David Chiswell should read 19,663 and not 259,934 as
previously shown.

All other details remain unchanged. The full corrected version is shown
below.'






                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1) Name of company
Cambridge Antibody Technology


2) Name of director
Kevin Johnson


3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above


4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above


5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)



6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under company CSOP scheme


7) Number of shares/amount of stock acquired



8) Percentage of issued class



9) Number of shares/amount of stock disposed



10) Percentage of issued class



11) Class of security



12) Price per share



13) Date of transaction



14) Date company informed



15) Total holding following this notification



16) Total percentage holding of issued class following this notification



If a director has been granted options by the company please complete the
following boxes

17) Date of grant
4 December 2001


18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011


19) Total amount paid (if any) for grant of the option
Nil


20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,260 shares


21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p


22) Total number of shares or debentures over which options held
following this notification
111,603


23) Any additional information



24) Name of contact and telephone number for queries
Diane Mellett 01763 263233


25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary


                     Date of Notification 5 December 2001

                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1) Name of company
Cambridge Antibody Technology


2) Name of director
John Aston


3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above


4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above


5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)



6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under company CSOP scheme


7) Number of shares/amount of stock acquired



8) Percentage of issued class



9) Number of shares/amount of stock disposed



10) Percentage of issued class



11) Class of security



12) Price per share



13) Date of transaction



14) Date company informed



15) Total holding following this notification



16) Total percentage holding of issued class following this notification



If a director has been granted options by the company please complete the
following boxes

17) Date of grant
4 December 2001


18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011


19) Total amount paid (if any) for grant of the option
Nil


20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,489 shares


21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p


22) Total number of shares or debentures over which options held
following this notification
202,472


23) Any additional information



24) Name of contact and telephone number for queries
Diane Mellett 01763 263233


25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary


Date of Notification 5 December 2001

                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1) Name of company
Cambridge Antibody Technology


2) Name of director
David Glover


3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above


4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above


5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)



6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under company CSOP scheme


7) Number of shares/amount of stock acquired



8) Percentage of issued class



9) Number of shares/amount of stock disposed



10) Percentage of issued class



11) Class of security



12) Price per share



13) Date of transaction



14) Date company informed



15) Total holding following this notification



16) Total percentage holding of issued class following this notification



If a director has been granted options by the company please complete the
following boxes

17) Date of grant
4 December 2001


18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011


19) Total amount paid (if any) for grant of the option
Nil


20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 13,260 shares


21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p


22) Total number of shares or debentures over which options held
following this notification
113,243


23) Any additional information



24) Name of contact and telephone number for queries
Diane Mellett 01763 263233


25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary


Date of Notification 5 December 2001

                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

1) Name of company
Cambridge Antibody Technology


2) Name of director
David Chiswell


3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a non-beneficial
interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18 or in respect of a
non-beneficial interest
As in 2 above


4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them (if notified)
As in 2 above


5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)



6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
Grant of options under company CSOP scheme


7) Number of shares/amount of stock acquired



8) Percentage of issued class



9) Number of shares/amount of stock disposed



10) Percentage of issued class



11) Class of security



12) Price per share



13) Date of transaction



14) Date company informed



15) Total holding following this notification



16) Total percentage holding of issued class following this notification



If a director has been granted options by the company please complete the
following boxes

17) Date of grant
4 December 2001


18) Period during which or date on which exercisable
4 December 2004 - 3 December 2011


19) Total amount paid (if any) for grant of the option
Nil


20) Description of shares or debentures involved: class, number
Ordinary 10p shares - 19,663 shares


21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
1704p


22) Total number of shares or debentures over which options held
following this notification
259,934


23) Any additional information



24) Name of contact and telephone number for queries
Diane Mellett 01763 263233


25) Name and signature of authorised company official responsible for
making this notification
Diane Mellett Company Secretary


Date of Notification 5 December 2001

Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024

Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024